Tag: Revolo Biotherapeutics

Revolo Biotherapeutics '1104

Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy

Revolog presents new data demonstrating long-lasting effect of '1104 candidate.
Revolo Therapeutics

Revolo Biotherapeutics Announces Open Enrollment for Phase 2 Clinical Trial of...

Revolo Biotherapeutics announced it has activated clinical sites and opened enrollment in a Phase 2 clinical trial of its eosinophilic esophagitis therapy.